Group One Trading
ABBV icon

Group One Trading’s AbbVie ABBV Stock Holding History

Group One Trading’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Buy
+1,609
New +$346K ﹤0.01% 3689
2024
Q3 		– Sell
-15,610
Closed -$2.91M – 6543
2024
Q2 		$2.68M Sell
15,610
-17,429
-53% -$2.89M 0.01% 1223
2024
Q1 		$6.02M Buy
+33,039
New +$5.69M 0.02% 719
2020
Q3 		– Sell
-56,443
Closed -$5.31M – 6008
2020
Q2 		$5.54M Sell
56,443
-79,339
-58% -$6.99M 0.03% 741
2020
Q1 		$10.3M Buy
+135,782
New +$11.6M 0.08% 245
2019
Q4 		– Sell
-104,044
Closed -$8.64M – 5037
2019
Q3 		$7.88M Sell
104,044
-108,201
-51% -$7.42M 0.06% 371
2019
Q2 		$15.4M Buy
212,245
+179,471
+548% +$14.1M 0.14% 140
2019
Q1 		$2.64M Buy
32,774
+29,560
+920% +$2.42M 0.03% 737
2018
Q4 		$296K Sell
3,214
-23,149
-88% -$2.04M ﹤0.01% 2378
2018
Q3 		$2.49M Buy
26,363
+52
+0.2% +$4.93K 0.02% 999
2018
Q2 		$2.44M Sell
26,311
-14,072
-35% -$1.37M 0.02% 992
2018
Q1 		$3.82M Buy
+40,383
New +$4.44M 0.04% 610
2016
Q3 		– Sell
-208,753
Closed -$13.5M – 4495
2016
Q2 		$12.9M Sell
208,753
-16,859
-7% -$1.03M 0.15% 124
2016
Q1 		$12.9M Sell
225,612
-127,414
-36% -$7.1M 0.18% 102
2015
Q4 		$20.9M Sell
353,026
-34,715
-9% -$2M 0.25% 57
2015
Q3 		$21.1M Buy
387,741
+75,424
+24% +$4.91M 0.29% 43
2015
Q2 		$21M Sell
312,317
-80,838
-21% -$5.28M 0.29% 52
2015
Q1 		$23M Buy
393,155
+285,521
+265% +$17.2M 0.36% 31
2014
Q4 		$7.04M Sell
107,634
-9,883
-8% -$623K 0.11% 189
2014
Q3 		$6.79M Buy
117,517
+87,324
+289% +$4.85M 0.1% 203
2014
Q2 		$1.7M Buy
+30,193
New +$1.58M 0.03% 800
2014
Q1 		– Sell
-76,344
Closed -$3.86M – 5129
2013
Q4 		$4.03M Sell
76,344
-17,701
-19% -$870K 0.06% 328
2013
Q3 		$4.21M Buy
94,045
+23,614
+34% +$1.05M 0.08% 259
2013
Q2 		$2.91M Buy
+70,431
New +$3.08M 0.07% 271

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Group One Trading's ABBV Position: Q2 2026 in Review

Group One Trading opened a new position in AbbVie (ABBV) in Q2 2026: 1,609 shares worth $405K. The stake represents ﹤0.01% of the portfolio and ranks #3689 among its holdings. This is a return to the name: Group One Trading previously reported a position in ABBV as recently as Q2 2024.

Group One Trading first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $23M in Q1 2015. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Group One Trading held 1,609 shares of AbbVie worth $405K as of Q2 2026.
  • AbbVie was a new Group One Trading position in Q2 2026.
  • AbbVie made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3689 holding.
  • Group One Trading first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • Group One Trading's AbbVie position peaked at $23M in Q1 2015.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.